Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
- Basic Statistic Major COVID-19 vaccines by number of countries using them March 2021
- Basic Statistic COVID-19 vaccines by contract size in doses by country and manufacturer 2021
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Basic Statistic COVID-19 vaccines contract size in doses by country and region 2021
- Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
- Basic Statistic Leading COVID-19 drugs, therapies and vaccines in development by early results 2020
About the region
10
- Basic Statistic COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023
- Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic Moderna total assets 2016-2023
- Basic Statistic Moderna net income 2016-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
Selected statistics
4
Other regions
10
- Basic Statistic Confirmed COVID-19 vaccine doses for Germany 2021, by manufacturer
- Basic Statistic COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Basic Statistic Confirmed COVID-19 vaccine doses for Finland 2021-2022, by manufacturer
- Basic Statistic Number of COVID-19 hospitalizations in Canada as of May 2, 2023, by age
- Basic Statistic Coronavirus (COVID-19) vaccination rate APAC June 2023, by country
- Basic Statistic COVID-19 vaccine adverse events in Spain 2022, by manufacturer
- Basic Statistic Adverse effect cases seriousness of vaccines against Covid-19 in France 2021
- Basic Statistic COVID-19 vaccines confirmed doses in Mexico 2022, by producer
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Number of COVID-19 vaccines ordered and delivered by Australia as of October 2021
Related statistics
10
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Total vaccine related funding by the National Institutes for Health 2013-2024
- Basic Statistic Moderna Inc collaboration revenue by related party 2018-2023
- Basic Statistic R&D expenses of Moderna by type 2023
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Premium Statistic Total global vaccine market size forecast 2028
- Basic Statistic Percent of registered clinical studies worldwide by type 2024
- Basic Statistic COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Sanofi's total assets 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Number of employees at Sinopharm 2011-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Sanofi's total assets 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Number of employees at Sinopharm 2011-2022
The Guardian. (March 6, 2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph]. In Statista. Retrieved May 09, 2024, from https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023." Chart. March 6, 2021. Statista. Accessed May 09, 2024. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. (2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023. Statista. Statista Inc.. Accessed: May 09, 2024. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and Sales Forecasts for Major Covid-19 Vaccines from 2021 to 2023." Statista, Statista Inc., 6 Mar 2021, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian, Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 Statista, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/ (last visited May 09, 2024)
Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph], The Guardian, March 6, 2021. [Online]. Available: https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/